We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$102B
AUM Growth
-$2.04B
Cap. Flow
-$1.16B
Cap. Flow %
-1.13%
Top 10 Hldgs %
10.73%
Holding
2,908
New
180
Increased
1,145
Reduced
1,360
Closed
133

Sector Composition

Rank Sector Weight
1 Technology 17.64%
2 Industrials 13.83%
3 Financials 12.36%
4 Consumer Discretionary 10.78%
5 Healthcare 9.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBII
2701
DELISTED
Marrone Bio Innovations, Inc.
MBII
$21K ﹤0.01%
23,533
-499
-2% -$601
PEI
2702
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$20K ﹤0.01%
674
-17
-2% -$520
SRGA
2703
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$19K ﹤0.01%
593
-29
-5% -$1.06K
ELOX
2704
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$18K ﹤0.01%
278
-31
-10% -$1.91K
TYME
2705
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$18K ﹤0.01%
17,048
-944
-5% -$1.04K
ARDX icon
2706
Ardelyx
ARDX
$997M
$17K ﹤0.01%
12,529
-70
-0.6% -$187
CASI
2707
DELISTED
CASI Pharmaceuticals
CASI
$17K ﹤0.01%
1,447
-117
-7% -$1.58K
DARE icon
2708
Dare Bioscience
DARE
$21M
$17K ﹤0.01%
+846
New +$16.7K
TLPH icon
2709
Talphera
TLPH
$74.2M
$17K ﹤0.01%
840
-42
-5% -$962
NXTP
2710
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
$17K ﹤0.01%
+621
New +$23.4K
EVFM
2711
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$16K ﹤0.01%
1,459
+94
+7% +$1.18K
ABEO icon
2712
Abeona Therapeutics
ABEO
$413M
$15K ﹤0.01%
534
-9
-2% -$288
SVRA icon
2713
Savara
SVRA
$1.19B
$15K ﹤0.01%
10,759
-343
-3% -$463
COCP icon
2714
Cocrystal Pharma
COCP
$14.6M
$14K ﹤0.01%
1,121
-57
-5% -$754
PTN
2715
Palatin Technologies
PTN
$13.8M
$14K ﹤0.01%
26
-1
-4% -$624
XTNT icon
2716
Xtant Medical Holdings
XTNT
$62.3M
$14K ﹤0.01%
12,876
-650
-5% -$845
XTIA icon
2717
XTI Aerospace
XTIA
$58.9M
0
BIOL
2718
DELISTED
Biolase, Inc.
BIOL
$14K ﹤0.01%
9
MARK
2719
DELISTED
Remark Holdings, Inc.
MARK
$14K ﹤0.01%
1,346
-55
-4% -$720
CATX icon
2720
Perspective Therapeutics
CATX
$342M
$13K ﹤0.01%
2,122
-107
-5% -$729
FTK icon
2721
Flotek Industries
FTK
$1.28B
$13K ﹤0.01%
1,686
-33
-2% -$297
UAMY icon
2722
United States Antimony
UAMY
$1.02B
$13K ﹤0.01%
14,788
+255
+2% +$235
IMNN icon
2723
Imunon
IMNN
$6.77M
$12K ﹤0.01%
66
-3
-4% -$623
VGZ icon
2724
Vista Gold
VGZ
$308M
$12K ﹤0.01%
16,874
+1,284
+8% +$1.1K
ZSAN
2725
DELISTED
Zosano Pharma Corporation
ZSAN
$12K ﹤0.01%
490
+14
+3% +$363

Similar funds

Victory Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Victory Capital Management held 2,908 positions worth $102B, down 2% from $104B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Victory Capital Management's Q3 2021 filing shows 180 new, 1,145 increased, 1,360 reduced and 133 closed positions. Its largest new stake was Stanley Black & Decker, Inc.: 824,973 shares worth $86.8M. The largest sale was Alphabet (Google) Class C, an estimated $243M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.

  • Victory Capital Management's largest Q3 2021 buy was Stanley Black & Decker, Inc.: 824,973 shares worth $86.8M.
  • Victory Capital Management added most to Newell Brands in Q3 2021, an estimated $214M increase.
  • Victory Capital Management's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $243M.
  • Victory Capital Management fully exited Core Mark Holding Co., Inc. in Q3 2021, selling an estimated $122M.
  • Victory Capital Management's ten largest holdings make up 11% of its $102B portfolio in Q3 2021.
  • Victory Capital Management opened 180 new positions and closed 133 in Q3 2021.
  • Victory Capital Management's portfolio value fell 2% quarter-over-quarter to $102B.

Based on Victory Capital Management's 13F filing for Q3 2021, filed 2 Nov 2021.